AU3922493A - Inhibition of P70 S6 kinase - Google Patents

Inhibition of P70 S6 kinase

Info

Publication number
AU3922493A
AU3922493A AU39224/93A AU3922493A AU3922493A AU 3922493 A AU3922493 A AU 3922493A AU 39224/93 A AU39224/93 A AU 39224/93A AU 3922493 A AU3922493 A AU 3922493A AU 3922493 A AU3922493 A AU 3922493A
Authority
AU
Australia
Prior art keywords
kinase
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39224/93A
Other languages
English (en)
Inventor
Joseph Avruch
Barbara E Bierer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Dana Farber Cancer Institute Inc
Original Assignee
General Hospital Corp
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Dana Farber Cancer Institute Inc filed Critical General Hospital Corp
Publication of AU3922493A publication Critical patent/AU3922493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/55—IL-2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU39224/93A 1992-04-07 1993-03-19 Inhibition of P70 S6 kinase Abandoned AU3922493A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86480692A 1992-04-07 1992-04-07
US864806 1992-04-07

Publications (1)

Publication Number Publication Date
AU3922493A true AU3922493A (en) 1993-11-08

Family

ID=25344112

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39224/93A Abandoned AU3922493A (en) 1992-04-07 1993-03-19 Inhibition of P70 S6 kinase

Country Status (2)

Country Link
AU (1) AU3922493A (fr)
WO (1) WO1993019752A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0710110B1 (fr) 1993-04-23 2002-03-06 Abbott Laboratories Anticorps de rapamycines a cycle ouvert
WO1994025072A1 (fr) * 1993-04-23 1994-11-10 American Home Products Corporation Conjugues de rapamycine et anticorps contre la rapamycine
US7279561B1 (en) 1993-04-23 2007-10-09 Wyeth Anti-rapamycin monoclonal antibodies
EP0942990A2 (fr) * 1996-10-31 1999-09-22 Novartis AG P70-s6k ou kinase apparentee, a activite constitutive
US6410312B1 (en) 1997-12-19 2002-06-25 Chiron Corporation huBUB3 gene involved in human cancers
AU7828698A (en) * 1997-06-11 1998-12-30 Chiron Corporation Detection of loss of the wild-type (hu)bub1 gene
AU4273099A (en) 1998-06-24 2000-01-10 Medical Research Council Polypeptides, polynucleotides and uses thereof
US6830909B1 (en) 1998-08-04 2004-12-14 Ludwig Institute For Cancer Research Identification and functional characterization of a novel ribosomal S6 protein kinase
WO2000008173A1 (fr) * 1998-08-04 2000-02-17 Ludwig Institute For Cancer Research Identification et caracterisation fonctionnelle d'une nouvelle proteine kinase s6 ribosomique
AU2003259803B2 (en) * 2002-08-12 2007-08-02 The Regents Of The University Of Michigan Diagnosis and treatment of tuberous sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093338A (en) * 1991-04-23 1992-03-03 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
US5102876A (en) * 1991-05-07 1992-04-07 American Home Products Corporation Reduction products of rapamycin

Also Published As

Publication number Publication date
WO1993019752A1 (fr) 1993-10-14

Similar Documents

Publication Publication Date Title
PL308553A1 (en) Inhibitors of farnesil-protein transferase
AU2588292A (en) Aminodiesters of rapamycin
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
AU4915796A (en) Inhibitors of prenyl transferases
AU4156293A (en) Thiazolylvinylphenyl derivatives
AU5218593A (en) Method of milling
PL306127A1 (en) Derivatives of epi-epibathydine
AU3731293A (en) Protein kinase c inhibitor
AU3708093A (en) Processes for the preparation of amylase inhibitor
AU8551191A (en) Inhibition of scale
AU4156993A (en) Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
AU4772493A (en) Sulfo-derivatives of adenosine
AU7720394A (en) Multi-unit ribozyme inhibition of oncogene expression
AU4788396A (en) Inhibition of angiogenesis using interleukin-12
AU3922493A (en) Inhibition of P70 S6 kinase
AU7175094A (en) Inhibition of interferon-gamma with oligonucleotides
AU5188093A (en) Fungicidal derivatives of 2-alkoxy-2-imidazolin-5-ones
AU5184393A (en) Substituted derivatives of diaminophthalimide
AU3406793A (en) 2-oxoquinoline derivatives
AU1990992A (en) Isolation of macrophage migration inhibition factor from ocular lens and dna which encodes the factor
AU6396394A (en) Products of the inhibition of advanced glycosylation
AU1783092A (en) Inhibitors of protein kinase c function
AU2504192A (en) Protein kinase c inhibition and novel compound balanol
AU3359493A (en) Determination of haptens